Literature DB >> 10223466

Percutaneous transfemoral embolization of an indirect carotid-cavernous fistula with cortical venous access to the cavernous sinus. Case report.

R J Bellon1, A Y Liu, J R Adler, A M Norbash.   

Abstract

The authors present the case of a 61-year-old man with an indirect carotid-cavernous fistula (CCF). Many now advocate a primary transvenous approach to deal with such lesions, with packing and thrombosis of the cavernous sinus leading to fistula obliteration. Transvenous access to the cavernous sinus via the inferior petrosal sinus is the usual route of access; both surgical and transfemoral superior ophthalmic vein approaches are also well described. In the case presented, the anatomy of the CCF was unfavorable for these approaches and its dominant venous egress was via a single enlarged arterialized cortical vein. The cavernous sinus was accessed with a transfemoral retrograde approach to the cortical draining vein. Successful CCF embolization was documented radiographically and clinically. To the authors' knowledge, this procedure has not been previously described in the English literature.

Entities:  

Mesh:

Year:  1999        PMID: 10223466     DOI: 10.3171/jns.1999.90.5.0959

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  10 in total

1.  Transvenous sonographically guided percutaneous access for treatment of an indirect carotid cavernous fistula.

Authors:  Turgut Berkmen; Neil A Troffkin; Ajay K Wakhloo
Journal:  AJNR Am J Neuroradiol       Date:  2003-09       Impact factor: 3.825

2.  Cavernous sinus dural fistula treated by transvenous facial vein approach.

Authors:  V Prochazka; V Cizek; R Kacirova
Journal:  Interv Neuroradiol       Date:  2004-10-22       Impact factor: 1.610

3.  Transvenous embolization of intracranial dural arteriovenous shunts through occluded venous segments: experience in 51 Patients.

Authors:  E Lekkhong; S Pongpech; K Ter Brugge; P Jiarakongmun; R Willinsky; S Geibprasert; T Krings
Journal:  AJNR Am J Neuroradiol       Date:  2011-07-28       Impact factor: 3.825

4.  A promising adjuvant to detachable coils for cavernous packing: onyx.

Authors:  X Lv; C Jiang; Y Li; Z Wu
Journal:  Interv Neuroradiol       Date:  2009-09-01       Impact factor: 1.610

5.  Endovascular treatment of a cavernous sinus dural arteriovenous fistula by transvenous embolisation through the superior ophthalmic vein via cannulation of a frontal vein.

Authors:  C Venturi; S Bracco; A Cerase; P Gennari; F Lorè; E Polito; A E Casasco
Journal:  Neuroradiology       Date:  2003-07-10       Impact factor: 2.804

6.  Multidisciplinary treatment of a large cerebral dural arteriovenous fistula using embolization, surgery, and radiosurgery.

Authors:  Cole A Giller; David W Barnett; Ike C Thacker; Joseph H Hise; Brian D Berger
Journal:  Proc (Bayl Univ Med Cent)       Date:  2008-07

7.  Embolisation of both fistulae through the same carotid artery tear in a patient with bilateral traumatic caroticocavernous fistulae.

Authors:  I Oran; H Bozkaya; M Parildar
Journal:  Neuroradiology       Date:  2004-02-03       Impact factor: 2.804

8.  Cavernous sinus dural fistulae treated by transvenous approach through the facial vein: report of seven cases and review of the literature.

Authors:  Alessandra Biondi; Dan Milea; Christophe Cognard; Giuseppe K Ricciardi; Fabrice Bonneville; Rémy van Effenterre
Journal:  AJNR Am J Neuroradiol       Date:  2003 Jun-Jul       Impact factor: 3.825

9.  Contralateral transvenous approach and embolization with 360° guglielmi detachable coils for the treatment of cavernous sinus dural fistula.

Authors:  Marco Zenteno; Santos-Franco Jorge; Moscote-Salazar Luis Rafael; AlvisMiranda Hernando Raphael; Alcala-Cerra Gabriel; Lee Ángel
Journal:  Asian J Neurosurg       Date:  2015 Jan-Mar

10.  Endovascular management of cavernous sinus dural arteriovenous fistulas: Overall review and considerations.

Authors:  Jong Min Lee; Eun Suk Park; Soon Chan Kwon
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2021-12-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.